November 04, 2021

M&A Watch: ‘Mission Critical’ Board Oversight

配信申込

ジャンプリンクテキスト

 

M&A WATCH: ‘MISSION CRITICAL’ BOARD OVERSIGHT

Boeing decision suggests importance of board oversight over critical risks and operations in Caremark claims

On September 7, 2021, a Delaware court largely denied The Boeing Company’s (“Boeing”) motion to dismiss a stockholder derivative suit against Boeing directors in connection with two crashes of Boeing’s 737 MAX airplane in October 2018 and March 2019. In In re The Boeing Company Derivative Litigation, No. 2019-0907-MTZ (Del. Ch. Sept. 7, 2021), the plaintiffs alleged, among other things, that Boeing’s board of directors had breached its fiduciary duty of oversight under the standards established in In re Caremark International Inc. Derivative Litigation, 698 A.2d 959 (Del. Ch. 1996) and Marchand v. Barnhill, 212 A.3d 805 (Del. 2019) by failing to establish an adequate reporting system for airplane safety and “turning a blind eye to a red flag representing airplane safety problems”. Though noting that Caremark claims are “possibly the most difficult theory in corporate law upon which a plaintiff might hope to win a judgment,” Vice Chancellor Zurn of the Delaware Court of Chancery (the “Court”), denied the defendants’ motion to dismiss on the basis that the plaintiffs had adequately pled facts to support the claim that the directors had breached their duty of oversight.

Special thanks to associate Joon Lee who contributed to this publication.

Read the full memo, ‘Mission Critical’ Board Oversight.

コンタクト

Scott Petepiece

パートナー

M&A

+1 212 848 8576

+1 212 848 8576

ニューヨーク

Alan S. Goudiss

パートナー

紛争解決

+1 212 848 4906

+1 212 848 4906

ニューヨーク

Daniel Litowitz

パートナー

M&A

+1 212 848 7784

+1 212 848 7784

ニューヨーク

Lona Nallengara

パートナー

キャピタルマーケッツ

+1 212 848 8414

+1 212 848 8414

ニューヨーク

Mallory Tosch Brennan

パートナー

紛争解決

+1 713 354 4847

+1 713 354 4847

+1 212 848 7657

+1 212 848 7657

ヒューストン

Lara Aryani

パートナー

M&A

+1 212 848 7556

+1 212 848 7556

ニューヨーク

Derrick Lott

パートナー

M&A

+1 212 848 7421

+1 212 848 7421

ニューヨーク

Roger Morscheiser

パートナー

M&A

+1 212 848 7422

+1 212 848 7422

ニューヨーク

地域